Skip to Content

Asmanex Approval History

  • FDA approved: Yes (First approved March 30th, 2005)
  • Brand name: Asmanex
  • Generic name: mometasone furoate
  • Dosage form: Inhalation Powder
  • Company: Schering-Plough Corporation
  • Treatment for: Asthma

Asmanex Twisthaler (mometasone furoate) is an inhaled corticosteroid for the treatment of asthma.

Development History and FDA Approval Process for Asmanex

Feb  4, 2008Approval FDA Approves Asmanex Twisthaler (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
Mar 30, 2005Approval FDA Approves Asmanex Twisthaler for Asthma

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.